Sapropterin
Sapropterin is a synthetic form of tetrahydrobiopterin (BH4), the natural cofactor for phenylalanine hydroxylase (PAH), used to treat phenylketonuria (PKU) and hyperphenylalaninemia in patients with BH4-responsive PAH deficiency. By supplementing or stabilizing the enzyme cofactor, it enhances residual PAH activity, lowering blood phenylalanine levels and allowing dietary liberalization. It is also investigated in cardiovascular disease due to BH4's role in endothelial nitric oxide synthase coupling.
Berat Molekul
241,2500 g/mol
LogP
-1,90
TPSA
132,00 Ų
Lipinski RO5
Lulus
Area Terapeutik
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Struktur 2D
Cite this structure
Embed this structure
SMILES
C[C@H](O)[C@H](O)[C@H]1CNc2nc(N)[nH]c(=O)c2N1
InChI
InChI=1S/C9H15N5O3/c1-3(15)6(16)4-2-11-7-5(12-4)8(17)14-9(10)13-7/h3-4,6,12,15-16H,2H2,1H3,(H4,10,11,13,14,17)/t3-,4+,6-/m0/s1
Molecular Formula
C9H15N5O3
HBD / HBA
6 / 6
Ikatan yang Dapat Dirotasi
2
Atom Berat
17
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
Pertanyaan yang Sering Diajukan
Sapropterin is a synthetic form of tetrahydrobiopterin (BH4), the natural cofactor for phenylalanine hydroxylase (PAH), used to treat phenylketonuria (PKU) and hyperphenylalaninemia in patients with BH4-responsive PAH deficiency. By supplementing or stabilizing the enzyme cofactor, it enhances residual PAH activity, lowering blood phenylalanine levels and allowing dietary liberalization. It is also investigated in cardiovascular disease due to BH4's role in endothelial nitric oxide synthase coupling.
Yes, Sapropterin is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201774. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 135398654. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="sapropterin"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/sapropterin/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/sapropterin/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/sapropterin/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="sapropterin"></drugfyi-drug>